Preferred Pharmaceuticals, Inc. recalls Lidocaine Ointment USP
- Published
- 14 Oct 2026
- Units affected
- N/A
- Agency
- FDA
- Country
- United States
The hazard
Failed Content Uniformity Specifications
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Lidocaine Ointment USP, 5% (Generic for Xylocaine), packaged in a 50 g jar, Rx only, Mfg: Taro Pharmaceuticals U.S.A., Inc., Prod# (NDC): 68788-7865-05
- Brand / company
- Preferred Pharmaceuticals, Inc.
- Codes / lots
- Lot #: F1925G, Expiry: 4/30/2027; Lot #: E0925T, Expiry: 4/30/2027; Lot # D3025M, Expiry: 4/30/2027; Lot #: D0825D, Expiry: 4/30/2027.
- Distribution
- USA Nationwide
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 14 Oct 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.